NEWAMSTERDAM PHARMA COMPANY

Ticker: NAMS CUSIP: N62509109 Class: Stock

Bain Capital Life Sciences Investors, LLC's Holding History (CIK: 0001703031)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 7,306,566 Value ($000) $256,314 Avg Close $36.39 Range $28.19 - $42.00
Q3 2025
Shares 10,719,110 Value ($000) $304,851 Avg Close $23.97 Range $17.97 - $28.91
Q2 2025
Shares 10,719,110 Value ($000) $194,123 Avg Close $18.24 Range $14.06 - $22.25
Q1 2025
Shares 10,719,110 Value ($000) $219,420 Avg Close $22.23 Range $17.18 - $26.80
Q4 2024
Shares 10,719,110 Value ($000) $275,481 Avg Close $21.24 Range $15.51 - $27.29
Q3 2024
Shares 10,473,913 Value ($000) $173,867 Avg Close $17.30 Range $15.19 - $21.48
Q2 2024
Shares 10,473,913 Value ($000) $201,204 Avg Close $20.06 Range $16.62 - $24.79
Q1 2024
Shares 10,473,913 Value ($000) $247,708 Avg Close $20.30 Range $11.18 - $26.35
Q4 2023
Shares 10,473,913 Value ($000) $116,994 Avg Close $9.16 Range $5.63 - $11.89
Q3 2023
Shares 10,473,913 Value ($000) $96,884 Avg Close $10.83 Range $8.57 - $12.54
Q2 2023
Shares 10,473,913 Value ($000) $124,535 Avg Close $13.27 Range $11.03 - $17.00
Q1 2023
Shares 8,300,000 Value ($000) $110 Avg Close $12.62 Range $9.50 - $18.70
Q4 2022
Shares 8,300,000 Value ($000) $90 Avg Close $9.95 Range $7.52 - $32.88